Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan vs Esomeprazole Triple Therapy for H. pylori
NCT06318104Phase 4Not yet recruiting
- Sponsor
- Hospital General de México "Dr. Eduardo Liceaga"
- Start
- Apr 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of tegoprazan in Helicobacter pylori infection (2 arms), sponsored by Hospital General de México "Dr. Eduardo Liceaga". Primary endpoints: Response to treatment by determining the eradication rate at 2 months and Compared Treatment-related adverse events at 2 months. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
tegoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06318104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06318104.